Weld Capital Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-4,470
Closed -$509K 521
2020
Q2
$509K Buy
+4,470
New +$474K 0.2% 181
2019
Q4
Sell
-4,452
Closed -$476K 674
2019
Q3
$476K Sell
4,452
-1,803
-29% -$185K 0.09% 398
2019
Q2
$637K Buy
+6,255
New +$601K 0.12% 304
2019
Q1
Sell
-8,275
Closed -$689K 705
2018
Q4
$689K Buy
+8,275
New +$776K 0.16% 240

Other funds holding DGX

Weld Capital Management's DGX Position: Q3 2020 in Review

Weld Capital Management sold out of Quest Diagnostics (DGX) in Q3 2020, closing a stake of 4,470 shares — an estimated $509K sold.

Weld Capital Management first reported a position in DGX in Q4 2018 and held it in 4 quarters. The position peaked at $689K in Q4 2018. 757 funds tracked by Wall St. Rank hold DGX as of Q3 2020.

  • Weld Capital Management reported no remaining Quest Diagnostics position as of Q3 2020 after selling out during the quarter.
  • Weld Capital Management sold 4,470 Quest Diagnostics shares in Q3 2020, an estimated $509K.
  • Weld Capital Management first reported a position in Quest Diagnostics in Q4 2018 and held it in 4 quarters.
  • Weld Capital Management's Quest Diagnostics position peaked at $689K in Q4 2018.
  • 757 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2020.

Based on Weld Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.